{"id":572,"date":"2014-05-29T07:18:03","date_gmt":"2014-05-29T07:18:03","guid":{"rendered":"http:\/\/www.asadkarim.co.uk\/?p=572"},"modified":"2014-05-29T07:18:03","modified_gmt":"2014-05-29T07:18:03","slug":"the-fundamentals-of-astrazeneca","status":"publish","type":"post","link":"https:\/\/www.asadkarim.co.uk\/?p=572","title":{"rendered":"The Fundamentals of AstraZeneca"},"content":{"rendered":"

The proposed takeover of the UK pharmaceutical giant AstraZeneca [http:\/\/www.astrazeneca.com<\/a>] by America’s Pfizer formally failed on Monday 26th May, when Pfizer failed to agree final price with the AstraZeneca board.<\/p>\n

Looking at the fundamentals of Astra Zeneca makes interesting reading<\/p>\n

[http:\/\/www.shareshop.hsbc.co.uk\/shareshop\/security.cgi?username=&ac=&csi=10009&record_search=1&search_phrase=az<\/a>]<\/p>\n

With a market capitalisation of about \u00a354 Billion<\/strong>, the dividend yield is over 3%.
\nIncredible to think in a 0.5% interest climate, the yield on AstraZeneca stock is 3.8%.<\/strong><\/p>\n

The specialisms of Astra Zeneca are:-<\/p>\n

[i]Cardiovascular and Metabolic disease (CVMD) <\/strong>
\n[ii]Oncology<\/strong>
\n[iii]Respiratory, Inflammation and Autoimmunity (RIA). <\/strong>
\n[iv]Infection, Neuroscience and Gastrointestinal (ING) disease areas<\/strong><\/p>\n

It’s\u00a0top ten products for\u00a0sales revenues are:-<\/p>\n

Crestor for managing cholesterol levels<\/em>: Sales \u00a33,337million<\/strong>
\nSeloken\/Toprol\u2013XL for hypertension, heart failure and angina<\/em>: Sales \u00a3445million<\/strong>
\nIressa for lung cancer<\/em>: Sales \u00a3384 million<\/strong>
\nFaslodex for breast cancer<\/em>: \u00a3404 million<\/strong>
\nZoladex for prostate and breast cancer:<\/em> \u00a3591 million<\/strong>
\nPulmicort for asthma<\/em>: \u00a3514 million<\/strong>
\nSymbicort for asthma<\/em>: \u00a32067 million<\/strong>
\nNexium for acid-reflux<\/em>: \u00a32298 million<\/strong>
\nSeroquel XR for schizophrenia, bipolar disorder and major depressive disorder<\/em>: \u00a3793 million<\/strong>
\nSynagis for RSV, a respiratory infection in infants<\/em>: \u00a3629 million<\/strong><\/p>\n

With around 51,500 people employed worldwide, 34.8% in Europe, 21.7% in North America, 6% in Central and South America, 4.1% in the Middle East and Africa and 33.4% in Asia Pacific.<\/p>\n

AstraZenca manufacture medicines and sales in sales in 2012 totalled \u00a315.2 billion<\/strong>, with Research and Development each year at \u00a32.37 billion<\/strong>. The flagship R&D facilities are in Cambridge.<\/p>\n

The 2nd largest Pharma company on the FTSE-100 index. Perhaps the reason for the takeover by Pfizer, was the 10 products that generated massive revenues and the R&D Pipeline from Cambridge.<\/p>\n","protected":false},"excerpt":{"rendered":"

The proposed takeover of the UK pharmaceutical giant AstraZeneca [http:\/\/www.astrazeneca.com] by America’s Pfizer formally failed on Monday 26th May, when Pfizer failed to agree final price with the AstraZeneca board. Looking at the fundamentals of Astra Zeneca makes interesting reading [http:\/\/www.shareshop.hsbc.co.uk\/shareshop\/security.cgi?username=&ac=&csi=10009&record_search=1&search_phrase=az] With a market capitalisation of about \u00a354 Billion, the dividend yield is over 3%. […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-572","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/www.asadkarim.co.uk\/index.php?rest_route=\/wp\/v2\/posts\/572","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.asadkarim.co.uk\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.asadkarim.co.uk\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.asadkarim.co.uk\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.asadkarim.co.uk\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=572"}],"version-history":[{"count":1,"href":"https:\/\/www.asadkarim.co.uk\/index.php?rest_route=\/wp\/v2\/posts\/572\/revisions"}],"predecessor-version":[{"id":573,"href":"https:\/\/www.asadkarim.co.uk\/index.php?rest_route=\/wp\/v2\/posts\/572\/revisions\/573"}],"wp:attachment":[{"href":"https:\/\/www.asadkarim.co.uk\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=572"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.asadkarim.co.uk\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=572"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.asadkarim.co.uk\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=572"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}